FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION

Tags

food and drug administration, FDA, FDA documents, FDA reports, FDA approval, FDA regulations, FDA recall, food safety, FDA news, department of public safety

You must be logged in to download this document

be first to review

FDADocs

FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Drug Safety and Risk Management Advisory Committee (DSaRM) Holiday Inn Gaithersburg Two Montgomery Village Avenue Gaithersburg, Maryland February 9 & 10, 2006 DRAFT AGENDA DAY ONE 8:00 a.m. Call to Order and Introductions Conflict of Interest Statement Peter Gross, M.D., Chair (DSaRM) Victoria Ferretti-Aceto, Pharm.D. Executive Secretary Drug Safety and Risk Management Advisory Committee Dr. Gerald Dal Pan, M.D., Director Office of Drug Safety Andrew Mosholder, M.D. 8:15 a.m. Opening Remarks 8:30 a.m. Attention Deficit Hyperactivity Disorder Drugs (ADHD)-Background Adverse Cardiovascular Events with ADHD drugs Update on Feasibility Studies (tentative) 9:00 a.m. Kate Gelperin, M.D. 9:30 a.m. David Graham, M.D. 10:00 a.m. Break 10:15 a.m. Challenges of Cardiovascular Drug Safety Epidemiology in Post Market Drug Arena 10:45 a.m. Question and Answer Period 11:30 a.m. Lunch 1:00 p.m. 2:00 p.m. 2:15 p.m. 2:30 p.m. 5:00 p.m. Open Public Hearing Break Introduction of Questions Committee Discussion of Questions Adjourn Gerald Dal Pan, M.D. To be announced FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Drug Safety and Risk Management Advisory Committee (DSaRM) Holiday Inn Gaithersburg Two Montgomery Village Avenue Gaithersburg, Maryland February 9 & 10, 2006 DRAFT AGENDA DAY TWO 8:00 a.m. Call to Order and Introductions Conflict of Interest Statement Peter Gross, M.D., Chair (DSaRM) Victoria Ferretti-Aceto, Pharm.D. Executive Secretary Drug Safety and Risk Management Advisory Committee 8:15 a.m. 9:15 a.m. Open Public Hearing General Office of Drug Safety Updates Gerald Dal Pan, M.D. Susan Cummins, M.D. 10:00 a.m. Drug Safety Oversight Board Update 10:30 a.m. Break 10:45 a.m. Risk Management Program, Status Update-NSAIDs and COX-2 Drugs 11:15 a.m. Introduction-Isotretinoin risk management program 11:30 a.m. Description of iPLEDGE 1:00 p.m. Adjourn Sharon Hertz, M.D. Jill Lindstrom, M.D. To be announced

Public Domain

downloads:0

rating:not rated

reviews:0

posted:5/9/2008

language:English

search termpage on Googletimes searched

food in drug administration office maryland21

FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION

Food and Drug Administration FDA Center for Drug

Food and Drug Administration FDA Center for Drug - 2005

Food and Drug Administration FDA Center for Drug Up

FDA A fillable

FDA CENTER FOR DRUG EVALUATION AND RESEARCH DIVISION

FDA CENTER FOR DRUG EVALUATION AND RESEARCH DIVISION

Irradiation of Food An FDA Perspective

Irradiation of Food An FDA Perspective Packaging

How FDA reviews drug names

FDA s Role in Responding to Drug Shortages

FDA Briefing Material Drug Shortages

FDA Prescription Drug Labeling Script

FDA Commissioner Dockets Management Food and Drug Fishers

Guidance Drug Safety Information FDA Communication to the Public

FDA Regulatory Pathway Annual FDA and the Changing

Pfizer DTC Hearing Abstract

ROTARIX Rotavirus Vaccine Live Oral

Section Pharmacological Research of VasoCleaner on Hyperlipidemia and Atherosclerosis

Section Documents regarding a Chinese Patent of the herbal formuIation

Section Toxicological tests of VasoCleaner in Mice and Rats

June Pre Market Notification Letter

Report on toxicity test of Xiwang capsule

August letter to Christopher Weisberg P A

Laboratoires Laphal DRD B P Allauch CEDEX France

Transmittal Letter and July letter to Christopher Weisberg P A